These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17024126)

  • 1. Study design and statistics in the epidemiology of breast cancer.
    Maraqa L; Lansdown M
    Br J Cancer; 2006 Nov; 95(9):1301; author reply 1302-3. PubMed ID: 17024126
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Maehlen J
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for breast cancer: is it globally applicable?
    Mittra I
    Nat Clin Pract Oncol; 2008 Feb; 5(2):60-1. PubMed ID: 18059392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Organized screening for breast cancer: the Vaud experience].
    De Landtsheer JP; Delaloye JF; Hessler C; De Grandi P; Paccaud F; Levi F
    Rev Med Suisse Romande; 2000 Jun; 120(6):501-10. PubMed ID: 11014094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening mammography: are epidemiology and common sense compatible?].
    Naldoni C
    Epidemiol Prev; 2002; 26(3):98-100. PubMed ID: 12197055
    [No Abstract]   [Full Text] [Related]  

  • 8. Some issues in screening for breast and other cancers.
    Duffy SW; McCann J; Godward S; Gabe R; Warwick J
    J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening in New Zealand.
    Blue J
    N Z Med J; 2005 Aug; 118(1221):U1626. PubMed ID: 16138164
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for breast cancer.
    Garr DR
    Am Fam Physician; 2000 Aug; 62(3):500-1. PubMed ID: 10950208
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: "Applying recursive partitioning to a prospective study of factors associated with adherence to mammography screening guidelines".
    Radespiel-Tröger M; Hothorn T; Pfahlberg AB; Gefeller O
    Am J Epidemiol; 2006 Aug; 164(4):400-1; author reply 401-2. PubMed ID: 16809428
    [No Abstract]   [Full Text] [Related]  

  • 12. Mammographic screening only matters in the detectable preclinical period of breast cancer.
    Broeders MJ; Verbeek AL
    J Med Screen; 2005; 12(2):107; author reply 107. PubMed ID: 15949123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Breast screening and statistics].
    Dige U
    Ugeskr Laeger; 2007 Mar; 169(11):1029. PubMed ID: 17378026
    [No Abstract]   [Full Text] [Related]  

  • 14. Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog?
    Tice JA; Feldman MD
    Breast Cancer Res Treat; 2008 Jan; 107(2):157-65. PubMed ID: 17377840
    [No Abstract]   [Full Text] [Related]  

  • 15. Whatever happened to clinical breast examinations?
    Caplan LS
    Am J Prev Med; 2004 Jul; 27(1):85. PubMed ID: 15212782
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australia's national breast screening program 18 years on: time for a new direction?
    Spillane AJ; Brennan ME
    ANZ J Surg; 2009 Oct; 79(10):674-6. PubMed ID: 19878156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Positive effects of breast cancer screening on mortality from breast cancer: 17 year DOM-project in Utrecht evaluated with a case control study].
    Broeders MJ; Peer PG; Verbeek AL
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):698-9. PubMed ID: 10321309
    [No Abstract]   [Full Text] [Related]  

  • 19. Tracking cancer screening progress.
    Hanson K; Bondurant E
    NCSL Legisbrief; 2009 Mar; 17(17):1-2. PubMed ID: 19301481
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.